Amarin (AMRN) Higher On Reports The Company Is Exploring Alternatives
Tweet Send to a FriendGet Alerts AMRN Hot Sheet
Down)
Trade AMRN Now!
Shares of Amarin (Nasdaq: AMRN) are higher in early action Tuesday following reports the company is hiring a financial advisor to explore strategic alternatives, including a possible sale.
CEO Joe Zakrzewski told Bloomberg News that the company has been approached by more than a dozen interested parties, potential partners and buyers.
"I have more companies interested in this asset than employees," he told Bloomberg at the J.P. Morgan Healthcare Conference in San Francisco.
Shares of Amarin last traded up 6.6 percent to $9.39.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
CEO Joe Zakrzewski told Bloomberg News that the company has been approached by more than a dozen interested parties, potential partners and buyers.
"I have more companies interested in this asset than employees," he told Bloomberg at the J.P. Morgan Healthcare Conference in San Francisco.
Shares of Amarin last traded up 6.6 percent to $9.39.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- NASDAQ OMX (NDAQ), Thomson Reuters (TRI) Enter Asset Purchase Agreement
- InterOil (IOC) Enters negotiations with ExxonMobil (XOM) on Development Of The Elk And Antelope Resource
Create E-mail Alert Related Categories
Corporate News, Mergers and Acquisitions, RumorsRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
